American Scientific Resources Announces Addition of New Board Member
WESTON, FL, October 8, 2009 - Weston, FLâ��October 8, 2009â�� American Scientific Resources, Inc. (Pink Sheets: ASFX), today announced the addition of a new member to the Company’s board of directors: Mr. Jason Roth, the Company’s newly appointed Senior Vice-President and Director of Business Development.Mr. Roth, a successful entrepreneur & marketing specialist in the medical supply industry, has taken great strides to advance the Company’s brand and provide for an additional revenue channel by introducing the world’s only FDA approved home needle destruction device, the Disintegrator Plus™, to ASR who acquired the exclusive selling and intellectual property rights from Safeguard Medical Technologies LLC. Safeguard connected with the world's largest healthcare enterprise, leading to a PO for 5000 Disintegrator units, and a follow up PO for 2000 units of which ASR will fulfill.
Mr. Roth will visit China this week where he will meet and contract with manufacturers and other service providers to assist ASR in the development and production of current and future products, including setting up a factory in China.
Dr. Christopher F. Tirotta, CEO for American Scientific commented, “We welcome Jason to the Board and look forward to seeing the results derived from his contacts and expertise.” â��
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is the parent company for wholly-owned subsidiaries, Kidz-Med and Heart Smart System. The Company's objective is to locate and acquire innovative health and safety products that are successfully sold abroad, and to introduce and promote them to the North American market. More information about the Company, including financial information, can be found on the ASFX web site at www.americansci.com. For product information, visit the Company's subsidiary, Kidz-Med at www.kidzmed.com.
Safe Harbor
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact:
Ronald Garner
ron@audiostocks.com
619-293-0621